Cargando…

Prospective experimental treatment of colorectal cancer patients based on organoid drug responses

BACKGROUND: Organoid technology has recently emerged as a powerful tool to assess drug sensitivity of individual patient tumors in vitro. Organoids may therefore represent a new avenue for precision medicine, as this circumvents many of the complexities associated with DNA- or transcriptional-profil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ooft, S.N., Weeber, F., Schipper, L., Dijkstra, K.K., McLean, C.M., Kaing, S., van de Haar, J., Prevoo, W., van Werkhoven, E., Snaebjornsson, P., Hoes, L.R., Chalabi, M., van der Velden, D., van Leerdam, M., Boot, H., Grootscholten, C., Huitema, A.D.R., Bloemendal, H.J., Cuppen, E., Voest, E.E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086019/ https://www.ncbi.nlm.nih.gov/pubmed/33887686 http://dx.doi.org/10.1016/j.esmoop.2021.100103

Ejemplares similares

Advancing molecular tumour boards: highly needed to maximise the impact of precision medicine
por: van de Haar, Joris, et al.
Publicado: (2019)

Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma
por: Dijkstra, Krijn K., et al.
Publicado: (2021)

Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas
por: Hoek, Jantien, et al.
Publicado: (2016)

Predicting clinical benefit from everolimus in patients with advanced solid tumors, the CPCT-03 study
por: Weeber, Fleur, et al.
Publicado: (2017)

Integrated Simulation Framework for Toxicity, Dose Intensity, Disease Progression, and Cost Effectiveness for Castration-Resistant Prostate Cancer Treatment With Eribulin
por: van Hasselt, JGC, et al.
Publicado: (2015)

Disease Progression/Clinical Outcome Model for Castration-Resistant Prostate Cancer in Patients Treated With Eribulin
por: van Hasselt, JGC, et al.
Publicado: (2015)

Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment
por: Hoes, Louisa R., et al.
Publicado: (2022)

Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literature
por: van Berge Henegouwen, J. M., et al.
Publicado: (2022)

Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics
por: Schipper, L.J., et al.
Publicado: (2022)

Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma Patients
por: Schipper, Luuk J., et al.
Publicado: (2022)

Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE)
por: Samsom, Kris G., et al.
Publicado: (2020)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)
por: Koemans, W. J., et al.
Publicado: (2019)

Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA study()()
por: Snoeren, Nikol, et al.
Publicado: (2017)

Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study
por: van der Kaaij, Rosa T, et al.
Publicado: (2017)

Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer
por: Rigter, Lisanne S., et al.
Publicado: (2022)

The influence of docetaxel schedule on treatment tolerability and efficacy in patients with metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials
por: van Eijk, Maarten, et al.
Publicado: (2022)

Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations
por: Willemsen, Annelieke E. C. A. B., et al.
Publicado: (2019)

Pan-cancer whole-genome analyses of metastatic solid tumours
por: Priestley, Peter, et al.
Publicado: (2019)

Diagnostic value of urinary mevalonic acid excretion in patietns with a clinical suspicion of mevalonate kinase deficiency (MKD)
por: Jeyaratnam, J, et al.
Publicado: (2015)

High Functioning Autism Spectrum Disorders in Adults: Consequences for Primary Caregivers Compared to Schizophrenia and Depression
por: Grootscholten, Inge A. C., et al.
Publicado: (2018)

Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management
por: Geukes Foppen, Marnix H, et al.
Publicado: (2018)

Response to “Cytomegalovirus Enterocolitis in a Patient with Refractory Immune-Related Colitis”
por: van Turenhout, Sietze, et al.
Publicado: (2021)

Incidence and treatment of hand and wrist injuries in Dutch emergency departments
por: van Leerdam, Roderick H., et al.
Publicado: (2021)

Feasibility of whole‐genome sequencing‐based tumor diagnostics in routine pathology practice
por: Samsom, Kris G, et al.
Publicado: (2022)

Factors influencing long‐term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms
por: van Eden, W. J., et al.
Publicado: (2019)

Diagnostic value of urinary mevalonic acid excretion in mevalonate kinase deficiency (MKD)
por: Jeyaratnam, Jerold, et al.
Publicado: (2014)

Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments
por: Kester, Lennart, et al.
Publicado: (2022)

The young ones and the old: past & future of science
por: van der Velden, J., et al.
Publicado: (2014)

Can innovation in endoscopic therapy alter clinical outcomes in patients with familial adenomatous polyposis?
por: van Leerdam, Monique E., et al.
Publicado: (2021)

Population Screening for Colorectal Cancer: Faeces, Endoscopes or X-Rays?
por: Ramsoekh, D., et al.
Publicado: (2007)

Overall and disease‐specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer
por: Rigter, Lisanne S., et al.
Publicado: (2018)

6th World Conference on 21st Century Mathematics
por: Cartier, Pierre, et al.
Publicado: (2015)

Short-term outcome after cystectomy: comparison of early oral feeding in an enhanced recovery protocol and feeding using Bengmark nasojejunal tube
por: Voskuilen, C. S., et al.
Publicado: (2017)

Author Correction: Caring for patients with cancer in the COVID-19 era
por: van de Haar, Joris, et al.
Publicado: (2020)

Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study
por: Ykema, Berbel L. M., et al.
Publicado: (2021)

Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity
por: Beerling, Evelyne, et al.
Publicado: (2016)

Adaptive designs in clinical trials in critically ill patients: principles, advantages and pitfalls
por: van Werkhoven, C. H., et al.
Publicado: (2018)

γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
por: de Vries, Natasja L., et al.
Publicado: (2023)

Molecular subtypes of breast cancer and amplification of topoisomerase IIα: predictive role in dose intensive adjuvant chemotherapy
por: Hannemann, J, et al.
Publicado: (2006)

Fixed Dosing of Monoclonal Antibodies in Oncology
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fvuuhqer12aclv98ndv0q7kd27